These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10901023)

  • 1. [Pathogenesis of rheumatoid arthritis].
    Alvaro-Gracia Alvaro JM
    Rev Clin Esp; 2000 May; 200 Monog 1():25-31. PubMed ID: 10901023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoimmune disorders in rheumatism and rheumatoid arthritis].
    Litvinenko AG
    Vrach Delo; 1980 Nov; (11):67-70. PubMed ID: 6970451
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acid phosphatase activity and the autoimmune processes in rheumatism and rheumatoid arthritis].
    Litvinenko AG
    Vopr Revm; 1980; (1):17. PubMed ID: 6966859
    [No Abstract]   [Full Text] [Related]  

  • 5. Arthritis: recent advances in theory and therapy.
    Stobo JD; Goetzl EJ
    Proc Inst Med Chic; 1982; 35(3):89-91. PubMed ID: 7145931
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
    Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
    Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired mixed leucocyte reaction in some different diseases, notably multiple sclerosis and various arthritides.
    Hedberg H; Källén B; Löw B; Nilsson O
    Clin Exp Immunol; 1971 Aug; 9(2):201-7. PubMed ID: 5570678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD30 in the maturation of thymocytes and in the pathogenesis of autoimmune diseases.
    Chiarle R; Inghirami G; Palestro G
    Pathologica; 2003 Oct; 95(5):229-30. PubMed ID: 14988980
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophages and their products in rheumatoid arthritis.
    Szekanecz Z; Koch AE
    Curr Opin Rheumatol; 2007 May; 19(3):289-95. PubMed ID: 17414958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
    Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
    Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathoetiology of chronic rheumatoid arthritis--from inflammation to bone destruction. 2) From the viewpoint of immunology].
    Sumida T
    Nihon Naika Gakkai Zasshi; 2000 Oct; 89(10):2064-71. PubMed ID: 11215118
    [No Abstract]   [Full Text] [Related]  

  • 12. B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
    Edwards JC; Cambridge G
    Nat Rev Immunol; 2006 May; 6(5):394-403. PubMed ID: 16622478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
    Feldmann M; Maini RN
    Nat Med; 2003 Oct; 9(10):1245-50. PubMed ID: 14520364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Abnormal gp130 signaling and autoimmune disease].
    Ishihara K; Atsumi T
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2336-42. PubMed ID: 12518458
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent developments in molecular therapeutic approaches for rheumatoid arthritis.
    Woods A; Hobson P; Klavinskis LS
    Curr Opin Mol Ther; 2004 Aug; 6(4):395-402. PubMed ID: 15468598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity and diseases. Autoimmunity and connective tissue.
    Glynn LE
    Folia Allergol (Roma); 1970; 17(4):433. PubMed ID: 5458002
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cause amd etiological mechanism of rheumatic arthritis using animal models].
    Sakaguchi S
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):497-8. PubMed ID: 11349640
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis.
    De Rycke L; Baeten D; Foell D; Kruithof E; Veys EM; Roth J; De Keyser F
    J Pathol; 2005 May; 206(1):17-27. PubMed ID: 15809977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapeutics that treat rheumatoid arthritis by blocking T-cell activation.
    MacKenzie NM
    Drug Discov Today; 2006 Oct; 11(19-20):952-6. PubMed ID: 16997147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 21 as a target of intervention in autoimmune disease.
    Ettinger R; Kuchen S; Lipsky PE
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii83-6. PubMed ID: 19022821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.